Vidar adds digitizer for mammography uses

Article

Vidar adds digitizer for mammography usesVidar Systems launched a new film digitizer at last month's Society of Breast Imaging meeting in Boston. Designed for digitizing mammography films, MammographyPro can support applications such as remote

Vidar adds digitizer for mammography uses

Vidar Systems launched a new film digitizer at last month's Society of Breast Imaging meeting in Boston. Designed for digitizing mammography films, MammographyPro can support applications such as remote primary diagnosis and computer-assisted diagnosis, according to the Herndon, VA-based firm. MammographyPro uses Vidar's High Definition CCD (HD-CCD) technology, and features a spot size of 31 microns, as well as an optical density range between zero and 3.65. MammographyPro will be available this summer, and will list at about $20,000.

In other Vidar news, the company will supply Jacksonville, FL-based StorComm with its DiagnosticPro and TeleRadPro digitizers. Vidar has also signed an agreement with Meta Solutions of Linthicum, MD, in which Meta will include Vidar products in its teleradiology and PACS offerings.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.